Hila Israelov1, Orly Ravid1, Dana Atrakchi1, Daniel Rand1,2, Shirin Elhaik1, Yael Bresler1,2, Rachel Twitto-Greenberg1,2, Liora Omesi1, Sigal Liraz-Zaltsman1,3,4, Fabien Gosselet5, Michal Schnaider Beeri1,6,7, Itzik Cooper8,9,10. 1. The Joseph Sagol Neuroscience Center, Sheba Medical Center, 52621, Tel Hashomer, Ramat Gan, Israel. 2. Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel. 3. Department of Pharmacology, The Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel. 4. Institute for Health and Medical Professions, Department of Sports Therapy, Ono Academic College, Kiryat Ono, Israel. 5. UR 2465, Blood-brain barrier Laboratory (LBHE), Artois University, F-62300, Lens, France. 6. School of Psychology, Interdisciplinary Center (IDC), Herzliya, Israel. 7. Department of Psychiatry, The Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. 8. The Joseph Sagol Neuroscience Center, Sheba Medical Center, 52621, Tel Hashomer, Ramat Gan, Israel. itzik.cooper@sheba.health.gov.il. 9. School of Psychology, Interdisciplinary Center (IDC), Herzliya, Israel. itzik.cooper@sheba.health.gov.il. 10. The Nehemia Rubin Excellence in Biomedical Research - The TELEM Program, Sheba Medical Center, Tel-Hashomer, Israel. itzik.cooper@sheba.health.gov.il.
Abstract
BACKGROUND: Excessive inflammation might activate and injure the blood-brain barrier (BBB), a common feature of many central nervous system (CNS) disorders. We previously developed an in vitro BBB injury model in which the organophosphate paraoxon (PX) affects the BBB endothelium by attenuating junctional protein expression leading to weakened barrier integrity. The objective of this study was to investigate the inflammatory cellular response at the BBB to elucidate critical pathways that might lead to effective treatment in CNS pathologies in which the BBB is compromised. We hypothesized that caspase-1, a core component of the inflammasome complex, might have important role in BBB function since accumulating evidence indicates its involvement in brain inflammation and pathophysiology. METHODS: An in vitro human BBB model was employed to investigate BBB functions related to inflammation, primarily adhesion and transmigration of peripheral blood mononuclear cells (PBMCs). Caspase-1 pathway was studied by measurements of its activation state and its role in PBMCs adhesion, transmigration, and BBB permeability were investigated using the specific caspase-1 inhibitor, VX-765. Expression level of adhesion and junctional molecules and the secretion of pro-inflammatory cytokines were measured in vitro and in vivo at the BBB endothelium after exposure to PX. The potential repair effect of blocking caspase-1 and downstream molecules was evaluated by immunocytochemistry, ELISA, and Nanostring technology. RESULTS: PX affected the BBB in vitro by elevating the expression of the adhesion molecules E-selectin and ICAM-1 leading to increased adhesion of PBMCs to endothelial monolayer, followed by elevated transendothelial-migration which was ICAM-1 and LFA-1 dependent. Blocking caspase-8 and 9 rescued the viability of the endothelial cells but not the elevated transmigration of PBMCs. Inhibition of caspase-1, on the other hand, robustly restored all of barrier insults tested including PBMCs adhesion and transmigration, permeability, and VE-cadherin protein levels. The in vitro inflammatory response induced by PX and the role of caspase-1 in BBB injury were corroborated in vivo in isolated blood vessels from hippocampi of mice exposed to PX and treated with VX-765. CONCLUSIONS: These results shed light on the important role of caspase-1 in BBB insult in general and specifically in the inflamed endothelium, and suggest therapeutic potential for various CNS disorders, by targeting caspase-1 in the injured BBB.
BACKGROUND: Excessive inflammation might activate and injure the blood-brain barrier (BBB), a common feature of many central nervous system (CNS) disorders. We previously developed an in vitro BBB injury model in which the organophosphate paraoxon (PX) affects the BBB endothelium by attenuating junctional protein expression leading to weakened barrier integrity. The objective of this study was to investigate the inflammatory cellular response at the BBB to elucidate critical pathways that might lead to effective treatment in CNS pathologies in which the BBB is compromised. We hypothesized that caspase-1, a core component of the inflammasome complex, might have important role in BBB function since accumulating evidence indicates its involvement in brain inflammation and pathophysiology. METHODS: An in vitro human BBB model was employed to investigate BBB functions related to inflammation, primarily adhesion and transmigration of peripheral blood mononuclear cells (PBMCs). Caspase-1 pathway was studied by measurements of its activation state and its role in PBMCs adhesion, transmigration, and BBB permeability were investigated using the specific caspase-1 inhibitor, VX-765. Expression level of adhesion and junctional molecules and the secretion of pro-inflammatory cytokines were measured in vitro and in vivo at the BBB endothelium after exposure to PX. The potential repair effect of blocking caspase-1 and downstream molecules was evaluated by immunocytochemistry, ELISA, and Nanostring technology. RESULTS: PX affected the BBB in vitro by elevating the expression of the adhesion molecules E-selectin and ICAM-1 leading to increased adhesion of PBMCs to endothelial monolayer, followed by elevated transendothelial-migration which was ICAM-1 and LFA-1 dependent. Blocking caspase-8 and 9 rescued the viability of the endothelial cells but not the elevated transmigration of PBMCs. Inhibition of caspase-1, on the other hand, robustly restored all of barrier insults tested including PBMCs adhesion and transmigration, permeability, and VE-cadherin protein levels. The in vitro inflammatory response induced by PX and the role of caspase-1 in BBB injury were corroborated in vivo in isolated blood vessels from hippocampi of mice exposed to PX and treated with VX-765. CONCLUSIONS: These results shed light on the important role of caspase-1 in BBB insult in general and specifically in the inflamed endothelium, and suggest therapeutic potential for various CNS disorders, by targeting caspase-1 in the injured BBB.
Authors: Tongrong He; Leslie A Smith; Sean Harrington; Karl A Nath; Noel M Caplice; Zvonimir S Katusic Journal: Stroke Date: 2004-09-02 Impact factor: 7.914
Authors: Svetlana M Stamatovic; Parvin Shakui; Richard F Keep; Bethany B Moore; Steven L Kunkel; Nico Van Rooijen; Anuska V Andjelkovic Journal: J Cereb Blood Flow Metab Date: 2005-05 Impact factor: 6.200
Authors: Hella Luksch; Michael J Romanowski; Osvaldo Chara; Victoria Tüngler; Ernesto R Caffarena; Michael C Heymann; Peter Lohse; Ivona Aksentijevich; Elaine F Remmers; Silvana Flecks; Nadine Quoos; Johannes Gramatté; Cathleen Petzold; Sigrun R Hofmann; Stefan Winkler; Frank Pessler; Tilmann Kallinich; Gerd Ganser; Antje Nimtz-Talaska; Ulrich Baumann; Volker Runde; Bodo Grimbacher; Jennifer Birmelin; Manfred Gahr; Joachim Roesler; Angela Rösen-Wolff Journal: Hum Mutat Date: 2012-08-10 Impact factor: 4.878
Authors: Michael T Heneka; Markus P Kummer; Andrea Stutz; Andrea Delekate; Stephanie Schwartz; Ana Vieira-Saecker; Angelika Griep; Daisy Axt; Anita Remus; Te-Chen Tzeng; Ellen Gelpi; Annett Halle; Martin Korte; Eicke Latz; Douglas T Golenbock Journal: Nature Date: 2012-12-19 Impact factor: 49.962
Authors: Fausta Ulgheri; Pietro Spanu; Francesco Deligia; Giovanni Loriga; Maria Pia Fuggetta; Iris de Haan; Ajay Chandgudge; Matthew Groves; Alexander Domling Journal: Eur J Med Chem Date: 2021-11-18 Impact factor: 6.514